![John Lunger](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Lunger
No open positions remaining
Net worth: 1 776 $ as of 31/05/2026
Profile
John Lunger formerly worked at Genocea Biosciences, Inc., as Independent Director, Merrimack Pharmaceuticals, Inc., as Head-Supply Chain & Commercial Product Supply, and Adaptimmune Therapeutics Plc, as Chief Patient Supply Officer from 2019 to 2025.
Mr. Lunger received his undergraduate degree from United States Naval Academy and Masters Business Admin degree from The University of Chicago Booth School of Business.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 11/04/2025 | 1,025,340 ( 0.06% ) | 1 025 $ | 31/05/2026 | |
Lipella Pharmaceuticals, Inc.
 Lipella Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes lipid-based therapies for common bladder syndromes 0.16% | 17/01/2025 | 7,510 ( 0.16% ) | 751 $ | 31/05/2026 |
Former positions of John Lunger
| Companies | Position | End |
|---|---|---|
| ADAPTIMMUNE THERAPEUTICS PLC | Corporate Officer/Principal | 29/08/2025 |
| MERRIMACK PHARMACEUTICALS | Corporate Officer/Principal | - |
| GENOCEA BIOSCIENCES, INC. | Director/Board Member | - |
Training of John Lunger
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
13
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Genocea Biosciences, Inc.
 Genocea Biosciences, Inc. BiotechnologyHealth Technology Operates as clinical stage biotechnology company that discovers and develops novel cancer immunotherapies | Health Technology |
Merrimack Pharmaceuticals, Inc.
 Merrimack Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes drugs for the treatment of immunological & autoimmune diseases and cancer | Health Technology |
United States Naval Academy
 United States Naval Academy Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Chicago Booth School of Business
 The University of Chicago Booth School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Adaptimmune Therapeutics Plc
 Adaptimmune Therapeutics Plc BiotechnologyHealth Technology Manufactures vaccines and cancer immunotherapy products | Health Technology |
- Stock Market
- Insiders
- John Lunger
